Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Market Access

Set Alert for Market Access

German Medtechs Aim To Score Useful Points In 2017 Election Year

The 2017 German national election, set for September 24, is not only a chance for Angela Merkel to secure a fourth term in office as Chancellor, but also an opportunity for the medtech industry to tell lawmakers how they can make the health-care system better. The medtech industry has made ten demands of the new government, with recent opinion polls favoring the status quo.

Germany Medical Device Reimbursement

Latest From Market Access

UK Medtech Upscales International Plans Ahead of Brexit

As the UK prepared to leave the EU, the local medtech industry, represented by the Association of British Healthcare Industries, has been busy finding ways to make up for any potential restrictions on market access and business development. On June 21, it announced a three-year growth plan, as explained by ABHI managing director of international Paul Benton in this Medtech Insight podcast interview.

United Kingdom Brexit

Turkey's Medtech Retailers And Pharmacists Lock Horns

Turkey's medical device retailers are up in arms over a recent government accord permitting the country's pharmacies to supply over 100 reimbursable medtech products to consumers and move in on the turf of these specialist medtech dealers. The latter is seeking legal action to overturn this agreement, although the outlook does not look optimistic.

Distribution Market Access

UK’s NICE Launching Online Tool To Help Medtech Demonstrate Value

Heath technology assessment organization NICE says its new online new tool will help medtech companies generate the evidence needed to demonstrate the value of their products to patients and payers.

Health Technology Assessment Reimbursement

India’s Simmering Device-Pricing Controversy – Many Hues

An uneasy calm prevails in the medical devices sector in India following regulatory action to cap stent prices and, more recently, a price data-gathering initiative for certain other products. Is this just the lull before another, more turbulent storm that lies ahead for industry?

India Pricing Strategies

IVD UK Spring Meeting: Diagnostics Get New Market Access Tools – But At A Price

First of two articles covering discussion at the spring 2017 meeting of the British In Vitro Diagnostics Association: The UK IVD companies are soon to get new tools designed to make market access for innovations easier and more predictable. This is welcome news, given the backdrop of Brexit and the costly route to compliance to the new EU IVD Regulation compliance.

United Kingdom Commercial

UK Medtech Market Access In Practice: Aim High But Stay Grounded

Manufacturers must ensure there are commercial outlets for the products they are developing, given the speed of change in medtech markets. That was the key message for companies and innovators at the UK Med-Tech Expo Conference 2017.

United Kingdom Market Access
See All